Dr Jeremy Braybrooke is a Consultant Medical Oncologist at University Hospitals Bristol NHS Foundation trust.

Dr Baybrook completed his undergraduate training at Southampton University and in Medical Oncology at the Cancer Research UK Medical Oncology unit in Oxford. During this time he completed a PhD, supervised by Professor Adrian Harris and Professor Ian Hickson, studying DNA damage and repair. He was appointed to his current consultant post in Bristol in 2003 and has developed a large patient focused clinical practice and is passionate about clinical research and improving patients' experience of chemotherapy treatments. He is actively involved in fund-raising for 'Above and Beyond' and 'It's in the Bag' charities improving awareness of testicular cancer.

Dr Braybrooke has been a member of the NICE Lung Cancer Clinical Guideline Development Group and currently sits on a NICE Technology Appraisal Committee evaluating new medicines. He is also a member of the American Society of Clinical Oncology, and was a member of the National Cancer Research Network Testicular Cancer Clinical Studies Group (2005 - 2010) and was Chair of Avon Somerset and Wiltshire Cancer Network Breast Cancer Site Specific Group (until April 2010)

Amit Bahl is Consultant Clinical Oncologist and Clinical Director based at The Bristol Haematology & Oncology Centre.

Dr Bahl has a special interest in breast and urological cancers.

He has led and developed the prostate brachytherapy service at Bristol.  He has been an expert adviser to NICE for the technology appraisal on new drugs and an external service reviewer. He has been awarded the fellowship of the Royal College of Physicians.

Dr Bahl is a current member of the National Cancer Research Institute for prostate and bladder cancer, and has supervised several research projects. He has previously been in the NCRI Renal clinical studies group. He is an Executive Committee member of the British Uro-oncology group. Dr Bahl is actively involved in research into breast, prostate and bladder cancers, participates in clinical trials and regularly publishes articles and has several presentations at national and international meetings.

In 2012, Dr Bahl was awarded the Cochrane Shanks Jalil Professorship by the Royal College of Radiologists, London.